Oppenheimer Oracle · ORCL

Oppenheimer Reiterates Outperform Rating on Oracle

Analyst: Brian Schwartz 1 min read Reproduced verbatim
Rating
Outperform
Unchanged
Target
$275
Unchanged
Upside
+137%
ORCL at $116 today
Oppenheimer and Oracle logos

What the analyst said

Oppenheimer analyst Brian Schwartz reiterated an Outperform rating and $275.00 price target on Oracle (NYSE: ORCL).

“We maintain our Outperform rating after Oracle reported the second-highest bookings quarter and above-consensus F4Q26 top- and bottom-line results.

Additionally, operating margin grew y/y for the first time in five quarters which suggests Oracle can grow profit margins by offsetting AI-driven gross margin compression with less Opex.

However, F4Q26 Cloud revenue missed Street estimate and F4Q26 Capex is 40% above consensus estimate. Further, Oracle’s 2HFY26 Capex and net income are essentially equal.

The Capex results and guidance leave tough optics and lend support to bear concerns about poor returns as Oracle transforms into a capital intensive business.

However, Oracle also generated $1.375 in CRPO for every $1 of Capex in FY26, which in our view, justifies the higher Capex and supports achieving the medium-term financial guidance.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $116. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $275 target is 18% above the median.

Since the note ORCL has moved −42% (from $201). 12-month window: day 148 of 365, closes on June 11, 2027.

Track record

This callOpen: ORCL has not reached $275 yet. This 12-month target is scored on June 8, 2027. Same target as this firm’s June 8, 2026 note, so it is scored there.

Firm track recordOppenheimer: 64% of its 14 targets at least a year old were reached within 12 months. Accuracy ranking →

Earnings reactionOne of 18 notes after Oracle’s Jun 10 results: 6 raised · 2 cut · 10 kept. See every call →

Oppenheimer on Oracle

Oppenheimer price targets on Oracle

7 calls from February 25, 2026 to October 29, 2026. The target went from $185 to $275 (+49%). The rating stayed Buy.

Oppenheimer targetORCL share price
  1. October 29, 2026Kept the $275 targetBuy$275
  2. September 11, 2026Kept the $275 targetBuy$275
  3. June 11, 2026 This noteKept the $275 targetBuy$275
  4. June 8, 2026Target raised from $235 (+17%)Buy$275
  5. May 12, 2026Target raised from $210 (+12%)Buy$235
  6. March 11, 2026Target raised from $185 (+14%)Buy$210
  7. February 25, 2026Earliest call shownBuy$185
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained Citizens JMPBuy Kept rating and price target Oct 29 $285maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.